Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/07Z0 stock hub

FRA/07Z0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/07Z0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/07Z0

In the news

Latest news · FRA/07Z0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.4

P25 n/aP50 n/aP75 n/a

Trailing P/E32

P25 n/aP50 n/aP75 n/a

ROE4.9

P25 n/aP50 n/aP75 n/a

ROIC5.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/07Z0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

CNY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	DE
Employees	8,689
Employees Change	-1,840%
Employees Change Percent	-17.27
Enterprise value	EUR 3.7B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 3.3B
Price	EUR 13
Price currency	EUR
Rev Per Employee	92,886.34x
Sic	3841
Symbol	fra/07Z0
Website	https://www.lepumedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.13%
EV Earnings	35.79x
EV/EBIT	25.38x
EV/EBITDA	24.21x
EV/FCF	48.5x
EV/Sales	4.66x
FCF yield	2.31%
Forward P/E	22.41x
P/B ratio	1.48x
P/E ratio	31.96x
P/S ratio	4.13x
PE Ratio10 Y	40.28x
PE Ratio3 Y	52.26x
PE Ratio5 Y	40.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.36%
FCF margin	9.54%
Gross margin	61.75%
Gross Profit	EUR 498.4M
Gross Profit Growth	17.48%
Gross Profit Growth Q	-6.69%
Gross Profit Growth3 Y	-15.62%
Gross Profit Growth5 Y	-7.76%
Net Income	EUR 104.4M
Net Income Growth	478.16%
Net Income Growth Q	-34.8%
Net Income Growth3 Y	-28.32%
Net Income Growth5 Y	-17.28%
Pretax Margin	15.74%
Profit Margin	12.94%
Profit Per Employee	EUR 12,015
ROA	2.9
Roa5y	4.87
ROCE	5.43
ROE	4.92
Roe5y	9.2
ROIC	5.16
Roic5y	9.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.64%
Cagr3y	-1.03%
EPS Growth	478.7
EPS Growth Q	-34.78
EPS Growth3 Y	-28.4
EPS Growth5 Y	-17.83
FCF Growth	67.42%
FCF Growth Q	-90.88%
FCF Growth3 Y	-22.58%
FCF Growth5 Y	-24.92%
OCF Growth	35.63%
OCF Growth Q	-34.4%
OCF Growth10 Y	10.44%
OCF Growth3 Y	-14.64%
OCF Growth5 Y	-16.01%
Revenue Growth	8.47x
Revenue Growth Q	-3.7x
Revenue Growth3 Y	-15.12x
Revenue Growth5 Y	-6.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.25
Assets	EUR 3.2B
Cash	EUR 501.7M
Current Assets	EUR 1.2B
Current Liabilities	EUR 483.9M
Debt	EUR 710.5M
Debt EBITDA	EUR 4.57
Debt Equity	EUR 0.31
Debt FCF	EUR 9.22
Equity	EUR 2.3B
Interest Coverage	4.22
Liabilities	EUR 957.1M
Long Term Assets	EUR 2.1B
Long Term Liabilities	EUR 473.1M
Net Cash	EUR -208.7M
Net Cash By Market Cap	EUR -6.25
Net Debt Equity	EUR 0.09
Net Debt FCF	EUR 2.71
Tangible Book Value	EUR 1.4B
Tangible Book Value Per Share	EUR 0.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.38
Inventory Turnover	1.25
Net Working Capital	EUR 450.6M
Quick ratio	1.71
Working Capital	EUR 672.9M
Working Capital Turnover	EUR 0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.1%
Dividend Growth	98.76%
Dividend Growth Years	1%
Dividend per share	EUR 0.18
Dividend Years	3
Dividend Yield	1.38%
Ex Div Date	2025-09-22
Last Dividend	EUR 0.1
Payout Ratio	94.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.64%
200-day SMA	13.31
3Y total return	-3.05%
50-day SMA	13.07
50-day SMA vs 200-day SMA	50under200
All Time High	15.86
All Time High Change	-18.03%
All Time High Date	2022-10-14
All Time Low	12.8
All Time Low Change	1.56%
All Time Low Date	2025-09-17
ATR	0.07
Ch YTD	-1.52
High	13
High52	13.7
High52 Date	2025-05-13
High52ch	-5.11%
Low	13
Low52	12.8
Low52 Date	2026-02-16
Low52ch	1.56%
Ma50ch	-0.51%
Price vs 200-day SMA	-2.3%
RSI	45.35
RSI Monthly	36.7
RSI Weekly	41.86
Sharpe ratio	-1.22x
Sortino ratio	-1.03
Total Return	1.47%
Tr YTD	-1.52
Tr1m	-0.76%
Tr3m	-1.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 148.1M
Operating Income Growth	292.6
Operating Income Growth Q	-16.72
Operating Income Growth3 Y	-24.56
Operating Income Growth5 Y	-13.88
Operating margin	18.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,131,696,634%
Net Borrowing	-37,660,241.5
Shares Insiders	13.02%
Shares Institutions	11.14%
Shares Qo Q	0.04%
Shares Yo Y	-0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 77M
Average Volume	0x
Bv Per Share	1.12
CAPEX	EUR -95.6M
Ch1m	-0.76
Ch1y	-2.99
Ch3m	-1.52
Ch3y	-6.47
Ch6m	-0.76
Change	0%
Change From Open	0
Close	13
Days Gap	0
Depreciation Amortization	50,860,834.3
Earnings Date	2026-04-23
EBIT	EUR 148.1M
EPS	EUR 0.06
F Score	7
FCF	EUR 77M
FCF EV Yield	2.06x
Financing CF	-147,245,902
Fiscal Year End	December
Founded	1,999
Goodwill	451,343,111.1
Graham Number	8.97651
Graham Upside	-30.95
Income Tax	EUR 18.2M
Investing CF	-34,112,456
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 2.03
Lynch Upside	-84.36
Ma150	13.12
Ma150ch	-0.88%
Ma20	13.09
Ma20ch	-0.69%
Net CF	-13,769,055
Next Earnings Date	2026-08-28
Open	13
P FCF Ratio	43.32
P OCF Ratio	19.33
Payment Date	2025-09-24
Ppne	513,319,007.9
Price Date	2026-04-30
Ptbv Ratio	2.46
Revenue	807,089,411x
Tax By Revenue	2.26x
Tax Rate	14.35%
Tr6m	-0.76%
Volume	0
Z Score	3.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/07Z0 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.18 annual per share

Payout ratio

+94.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-09-22

Performance

FRA/07Z0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/07Z0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.1%

Share of float held by funds and institutions

Insider ownership

+13.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

FRA/07Z0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

-2.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/07Z0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/07Z0 stock rating?

fra/07Z0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/07Z0 analysis?

The full report lives at /stocks/fra/07Z0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/07Z0?

The latest report frames fra/07Z0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/07Z0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.